<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>isfcppharmaspire</PublisherName>
<JournalTitle>Pharmaspire</JournalTitle>
<PISSN>C</PISSN>
<EISSN>o</EISSN>
<Volume-Issue>Volume 15, Issue 04, 2023</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>October-December</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>2024</Year>
<Month>02</Month>
<Day>17</Day>
</PubDate>
<ArticleType>Pharmaceutics</ArticleType>
<ArticleTitle>Formulation and evaluation of oral medicated jelly of meclizine HCl</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>225</FirstPage>
<LastPage>229</LastPage>
<AuthorList>
<Author>
<FirstName>Abhay Murari Lal</FirstName>
<LastName>Verma</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Poonam</FirstName>
<LastName>Negi</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI>10.56933/Pharmaspire.2023.15134</DOI>
<Abstract>The present study is conducted with the aim of formulating and evaluating an oral medicated jelly of meclizine hydrochloride for the treatment of motion sickness, nausea, and vomiting. Jellies are thick viscous fluid to semisolid in nature. The jellies form can be swallowed easily without water and they are soft and smooth. Medicated jellies of meclizine hydrochloride were formulated using polymers such as gelatin, pectin, and sodium alginate. The prepared medicated jellies were evaluated for their physico-chemical properties such as appearance, stickiness, pH, viscosity, drug release, and drug content.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>Gelatin, Jellies, Meclizine HCl, Pectin, Sodium alginate</Keywords>
<URLs>
<Abstract>https://isfcppharmaspire.com/ubijournal-v1copy/journals/abstract.php?article_id=15068&title=Formulation and evaluation of oral medicated jelly of meclizine HCl</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>1. Yokoyama H, Hirata A, Hamamoto H, Ishibashi M, Yamasaki K, Fujii T. Biguanide Drug-containing Jelly Preparation (Patent No. US 2007/0053939A1). United States Patent and Trademark Office (USPTO); 2007. Available from: https://patents.google.com/patent/us20070053939a1/en?inventor=hideakira+yokoyama and;country=us [Last accessed on 2007 Mar 08].
2. Carter CJ. Cooper and Gunn’s Dispensing for Pharmaceutics. 20th ed. New Delhi: CBS; ?2008. p. 214-6.
3. Dosani MA, Sakarkar DM, Koslage SB, Sheikh S. Formulation development and evaluation of unit moulded herbal semisolid jelly useful in treatment of mouth ulcer. Int J PharmTech Res 2011;3:1705-13.
4. Zuniga RN, Aguilera JM. Aerated food gels: Fabrication and potential applications. Trend Food Sci Technol 2008;19:176-87.
5. Prakash K, Satyanarayanan VM, Nagiat HT, Fathi AH, Shanta AK, Prameela AR. Formulation development and evaluation of novel oral jellies of carbamazepine using pectin, guar gum, and gellan gum. Asian J Pharm 2014;8:241-9.
6. Verma AM, Palani S. Development and in-vitro evaluation of liposomal gel of ciclopirox olamine. Int J Pharma Bio Sci 2010;1:1-6.
7. Kati B. Nausea and Vomiting, Healthline Medical Review Team, Sept.26, 2015. Available from: https://my.clevelandclinic.org/health/articles/nausea-and vomiting [Last accessed on 2017 Aug 09].
8. Melinda R. Digestive Disorder Health Center, (Nausea and Vomating). New York: WebMD Medical; 2014.
9. Erskine KS. Motion Sickness, Centers for Disease Control and Prevention. Atlanta: Centers for Disease Control and Prevention; 2015.
10. Salunke T, Mayee R. Formulation and evaluation of medicated jelly of bitter drug. Int J Pharm Innov 2013;3:1-14.
11. Imai K. Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: Review of a novel, easy to swallow formulation. Clin Interv Aging 2013;8:681-8.
12. Eisai Launches New Oral Jelly Formulation of Aricept®, World’s First Oral Jelly Formulation for Alzheimer’s Disease Treatment; 2009. Available from: https://www.eisai.com/news/news200950.html [Last accessed on 2009 Dec 01].
13. Jani GK, Shah DP, Prajapti VD, Jain VC. Gums and mucilages: Versatile excipients for pharmaceutical formulations. Asian J Pharm Sci 2009;4:308-22.
14. Verma AM, Pundir S. Oral disintegrating preparationmedicated chewing gum. Pharma Utility 2014;8:1-19.
15. Excipient Performance (1059). USP35-NF30, Pharmacopeial Forum. Vol. 35., No. 5. Rockville: United States Pharmacopeial Convention; 2012. p. 598, 1228.
16. Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients. 6th ed. London: Pharmaceutical Press; 2009.
17. Kubo W, Miyazaki S, Attwood D. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int J Pharm 2003;258:55-64.
18. Alhaique F, Santucci E, Carafa M, Coviello T, Murtas E, Riccieri FM. Gellan in sustained release formulations: Preparation of gel capsules and release studies. Biomaterials 1996;17:1981-6.
19. Sworn G, Kasapis S. Effect of conformation and molecular weight of co-solute on the mechanical properties of gellan gum gels. Food Hydrocoll 1998;12:283-90.
20. Rowe R, Sheskey P, Weller P, editors. Handbook of Pharmaceutical Excipients. 4th ed. Chicago: The Pharmaceutical Press; 2003.</References>
</References>
</Journal>
</Article>
</ArticleSet>